&quot;ICYMI: @garciamanero, of @MDAndersonNews, discusses why the novel drug emavusertib, an IRAK4 inhibitor, is a potential treatment option for patients with hematologic malignancies. https://t.co/kxedjPe0xt&quot;

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Mar 5, 2023